The quarter growth has been in-line with expectations, says Om Manchanda, CEO of Dr Lal PathLabs adding that some operational expenses will be seen in the next nine months. Money Control, 3 weeks ago
Expect Dr Lal PathLabs to surpass industry growth in FY17: CEO - Money Control, 2 months ago
Mumbai-based pathology chain operator Metropolis Healthcare Ltd has exited South Africa due to lack of growth and regulatory hurdles and restructured its Middle East business, managing director Ameera Shah told VCCircle. The exit from South ...VC Circle, 2 weeks ago
Kolkata: Dr Lal PathLabs, India's biggest pathology chain, is looking for acquisition of medium and small pathology firms, especially in western and southern parts of the country. To spread its footprint in the east, the pathology major is coming up ...Times of India, 2 weeks ago Dr Lal PathLabs eyeing 18 pc growth in FY17 Times of India, 2 months ago Dr Lal PathLabs eyeing 18% growth in FY17 Moneycontrol.com, 2 months ago Dr Lal PathLabs eyeing 18 per cent growth in FY17 Economic Times, 2 months ago
Director Sanjay Gadhvi, who directed the first two installments of the popular franchise 'Dhoom', says that he is open to directing another part but is currently working on something independent. Speaking on the sidelines of the Indian Mobile ...Times of India, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!